Skip to main content
DNA Labs India

RB1 Gene Hereditary Retinoblastoma NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

RB1 Gene Hereditary Retinoblastoma NGS Genetic Test

Short Name: RB1 Hereditary Retinoblastoma NGS

Also known as: RB1 Mutation Analysis, Hereditary Retinoblastoma NGS Panel, Retinoblastoma Gene Sequencing

RB1 Gene Hereditary Retinoblastoma NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Reports are usually available within 3 to 4 weeks after the sample is received at the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAll age groups (commonly children)🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the RB1 gene hereditary retinoblastoma NGS genetic test is to identify pathogenic variants in the RB1 gene that cause hereditary retinoblastoma. It is used for diagnostic confirmation in clinically affected children and for predictive testing in at-risk family members. Determining the genetic basis helps distinguish hereditary and sporadic forms and informs lifelong cancer surveillance and reproductive counselling.

Test Code
3845
CPT Code
N/A
ICD Code
N/A
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Reports are usually available within 3 to 4 weeks after the sample is received at the laboratory.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. Please bring any previous eye examination reports and family history details. A genetic counselling session is recommended to draw a pedigree chart of affected family members.

Method: Blood collection / dried blood spot / submitted DNA sample

Step 2

Laboratory Analysis

A trained phlebotomist will collect a blood sample in an EDTA tube, or a single drop of blood can be placed on an FTA card. The collection procedure is quick and minimally invasive.

Step 3

Report Delivery

The sample will be transported to the laboratory for NGS analysis. The patient can resume normal daily activities immediately after sample collection.

Timeline: Reports are usually available within 3 to 4 weeks after the sample is received at the laboratory.

Patient Instructions

1
Before the Test:No special preparation is needed. No fasting is required. A genetic counselling session is recommended to review family history and understand the implications of the test.
2
During the Test:A blood sample is collected in an EDTA tube or a blood spot is applied to an FTA card. If extracted DNA is being submitted, it is transported according to laboratory instructions.
3
After the Test:The sample is processed in the laboratory using NGS technology. The report is shared within 3 to 4 weeks, and the patient can continue daily activities immediately.

About This Test

Who Should Get This Test

The purpose of the RB1 gene hereditary retinoblastoma NGS genetic test is to identify pathogenic variants in the RB1 gene that cause hereditary retinoblastoma. It is used for diagnostic confirmation in clinically affected children and for predictive testing in at-risk family members. Determining the genetic basis helps distinguish hereditary and sporadic forms and informs lifelong cancer surveillance and reproductive counselling.

How to Prepare

  • Home sample collection is available for online bookings
  • Please confirm the sample type (blood / FTA card / extracted DNA) with the laboratory
  • Label the sample with patient name and collection date
  • Ensure FTA card is air-dried and stored in a clean, dry pouch
  • Carry a valid identification document and clinical history sheet

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"A confirmed RB1 mutation has important implications for the child and the family. Genetic counselling should accompany testing to help families understand recurrence risks and plan appropriate surveillance."

Last medically reviewed: September 3, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample VolumeAs required by laboratory
ContainerEDTA tube / FTA card / sterile DNA tube
Collection MethodBlood collection / dried blood spot / submitted DNA sample

Sample Stability

Sample Rejection Criteria:
  • Insufficient sample quantity
  • Hemolyzed or clotted blood sample
  • Improperly labelled sample
  • Sample not received in appropriate container
  • Missing clinical history or consent documentation

Understanding Your Results

The clinical report should be interpreted together with the patient's eye examination findings, tumour laterality, age at diagnosis and family history. A clinical geneticist can provide an integrated interpretation and guide next steps.
📊

Pathogenic variant detected

Confirms hereditary retinoblastoma. Genetic counselling and predictive testing for family members are recommended.

📊

Likely pathogenic variant detected

Suggests hereditary retinoblastoma. Additional family segregation studies may be useful.

📊

Variant of uncertain significance (VUS)

The clinical impact is unknown. Further testing of family members may help clarify the significance.

📊

No pathogenic variant detected

Reduces the likelihood of hereditary retinoblastoma but does not completely rule it out. Clinical correlation is required.

⚠️ When to Consult a Doctor:

Parents should consult an ophthalmologist immediately if a child has a white glow in the pupil, crossed eyes, poor vision, eye redness or a family history of retinoblastoma. If there is a known RB1 mutation in the family, a clinical geneticist can help plan predictive testing and surveillance.

Limitations

  • May not detect variants in deep intronic regions not covered by the NGS assay
  • Large deletions or duplications may not be reliably detected by sequencing alone
  • A variant of uncertain significance may not provide a definitive clinical answer
  • Negative results do not completely exclude the possibility of hereditary retinoblastoma

Risks & Considerations

  • Minimal physical risk from blood sample collection
  • No direct medical treatment risk from the genetic test
  • Possible psychological stress from receiving genetic information
  • Risk of incidental findings that may affect other family members

Interfering Factors

  • Low-quality or degraded DNA
  • Low-level mosaicism may not be detected
  • Large structural rearrangements may require additional deletion/duplication analysis
  • Sample contamination or incorrect labelling
  • Insufficient DNA quantity

Compare With Similar Tests

TestRB1 Gene Hereditary Retinoblastoma NGS Genetic TestRB1 NGS Genetic TestRB1 NGS Genetic Test
ComparisonRB1 Gene Hereditary Retinoblastoma NGS Genetic Test

Frequently Asked Questions

What is the RB1 gene hereditary retinoblastoma NGS genetic test?
It is a next-generation sequencing test that looks for changes in the RB1 gene to help diagnose hereditary retinoblastoma.
Why is this test done?
It helps confirm whether a clinically detected retinoblastoma is related to a hereditary RB1 gene mutation, which guides treatment and family screening.
What is the cost of this test?
DNA Labs India offers this test at a price of INR 20,000, with free home sample collection available in many cities.
What sample is required?
Blood, extracted DNA, or one drop of blood on an FTA card can be used for this test.
Is fasting required before the test?
No, this genetic test does not require fasting.
How long will the reports take?
Test reports are generally available within 3 to 4 weeks after the sample is received.
Can NGS detect all RB1 mutations?
NGS is highly sensitive for detecting point variants and small insertions/deletions, but some large deletions or duplications may require additional methods.
Does a negative result rule out hereditary retinoblastoma?
No. A negative result reduces the likelihood but does not completely exclude hereditary retinoblastoma. Results should be correlated with clinical and family history.
Who should be tested?
Children with retinoblastoma, especially bilateral or early-onset disease, and at-risk family members after genetic counselling.
What is a variant of uncertain significance?
A VUS is a genetic change whose impact on health is not yet known. Additional family studies may help clarify its significance.
Do I need genetic counselling?
Yes, genetic counselling is recommended before and after the test to understand the implications of the results for the child and family.
Will I receive raw data?
DNA Labs India provides raw data files such as FASTQ and VCF along with the conclusive clinical report for transparency.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.